Literature DB >> 3212150

Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles.

H V Curran1, M Sakulsriprong, M Lader.   

Abstract

The effects on memory and psychomotor functions of four antidepressants which differ in sedative and anticholinergic properties were assessed. Amitriptyline (37.5, 70 mg), trazodone (100, 200 mg) viloxazine (100, 200 mg), protriptyline (10, 20 mg) or placebo were administered in a double blind, independent groups design in which 90 subjects participated. Subjects completed a battery of tests before and 2 and 4 h after drug administration. The different antidepressants produced different patterns of effects across tasks. The relatively non-sedating compounds viloxazine and protriptyline produced very similar profiles and did not impair psychomotor or memory functions. In contrast, the two more sedative antidepressants produced global impairments on test of attention, manual motor speed, recording skills and primary memory. Although both amitriptyline and trazodone impaired performance on episodic memory tasks, the effect of amitriptyline was significantly greater and this may reflect specific anticholinergic action over and above global sedative effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3212150     DOI: 10.1007/bf00172967

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  The newer antidepressants: structures, pharmacokinetics, pharmacodynamics, and proposed mechanisms of action.

Authors:  E Richelson
Journal:  Psychopharmacol Bull       Date:  1984

2.  Lack of anticholinergic side effects with a new antidepressent--trazodone.

Authors:  S Gershon; R Newton
Journal:  J Clin Psychiatry       Date:  1980-03       Impact factor: 4.384

3.  Non-MAOI antidepressant drugs and cognitive functions: a review.

Authors:  P J Thompson; M R Trimble
Journal:  Psychol Med       Date:  1982-08       Impact factor: 7.723

4.  Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.

Authors:  H V Curran; W Schiwy; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  The clinical pharmacology of viloxazine hydrochloride-a new anti-depressant of novel chemical structure.

Authors:  P F Bayliss; S M Duncan
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

Review 6.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

7.  Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome".

Authors:  O M Wolkowitz; H Weingartner; K Thompson; D Pickar; S M Paul; D W Hommer
Journal:  Am J Psychiatry       Date:  1987-01       Impact factor: 18.112

8.  Models of cognitive impairment: cognitive changes in depression.

Authors:  H Weingartner; E Silberman
Journal:  Psychopharmacol Bull       Date:  1982-04

9.  Amitriptyline selectively disrupts verbal recall from secondary memory of the normal aged.

Authors:  R J Branconnier; D R DeVitt; J O Cole; K F Spera
Journal:  Neurobiol Aging       Date:  1982       Impact factor: 4.673

10.  Qualitative analysis of scopolamine-induced amnesia.

Authors:  E D Caine; H Weingartner; C L Ludlow; E A Cudahy; S Wehry
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  15 in total

1.  Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline.

Authors:  H Allain; A Lieury; F Brunet-Bourgin; C Mirabaud; P Trebon; F Le Coz; J M Gandon
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Pharmacoeconomic evaluation of antidepressants : a critical appraisal of methods.

Authors:  Sheikh Usman Iqbal; Mark Prashker
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

Review 4.  A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.

Authors:  Cara Tannenbaum; Amélie Paquette; Sarah Hilmer; Jayna Holroyd-Leduc; Ryan Carnahan
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

5.  The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.

Authors:  D Allen; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.

Authors:  J Fritze; M Lanczik; E Sofic; M Struck; P Riederer
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

7.  A dose-response study of the effects of inhaled nitrous oxide on psychological performance and mood.

Authors:  D Fagan; D L Paul; B Tiplady; D B Scott
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

8.  Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo.

Authors:  M Sakulsripong; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Memory and psychomotor effects of oxcarbazepine in healthy human volunteers.

Authors:  H V Curran; R Java
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.